Details for New Drug Application (NDA): 012699
✉ Email this page to a colleague
NDA 012699 describes LOMOTIL, which is a drug marketed by Gd Searle Llc and Pfizer and is included in two NDAs. It is available from three suppliers. Additional details are available on the LOMOTIL profile page.
The generic ingredient in LOMOTIL is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
The generic ingredient in LOMOTIL is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
Summary for 012699
| Tradename: | LOMOTIL |
| Applicant: | Gd Searle Llc |
| Ingredient: | atropine sulfate; diphenoxylate hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 0.025MG/5ML;2.5MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
